Viking Therapeutics (VKTX) Stock News: September 2026
$VKTX · 4 stories in September 2026September 2026
newest first · direct subject stories onlyViking Therapeutics closed its upsized offerings of 9,035,714 common shares at $35.00 each and $258.75M in 2.00% convertible notes due 2032. Underwriters fully exercised options on both tranches. Net proceeds of ~$547.8M will fund VK2735 and VK3019 programs.
neutral 50 · impact 30